Modex Therapeutics

IN THE PRESS

Press Releases

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

June 10, 2025

·

7 min read

Press Releases

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

January 7, 2025

·

5 min read

Press Releases

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

October 7, 2024

·

7 min read

Press Releases

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

September 24, 2024

·

4 min read

Drug Development

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

March 5, 2024

·

6 min read

Genetown

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

September 28, 2023

·

7 min read

Business

Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health’s ModeX Therapeutics

May 23, 2023

·

3 min read

BioMidwest

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

March 8, 2023

·

6 min read

JOBS